Status:
COMPLETED
Anti-aging and Anti-oxidant Efficacy Evaluation of the MelaGene
Lead Sponsor:
TCI Co., Ltd.
Conditions:
Aging
Antioxidative Stress
Eligibility:
All Genders
30-65 years
Phase:
NA
Brief Summary
The primary purpose of the present study is to evaluate the effects of MelaGene on anti-aging and anti-oxidant.
Eligibility Criteria
Inclusion
- 30 to 65-year-old;
- Must read and sign the informed consent form before the experiment;
- People who are willing to cooperate with contraception during the trial period;
- Do not change lifestyle and eating habits arbitrarily during the trial period;
- Do not take supplementary foods and health supplements with the same efficacy two weeks before and during the test;
- If any adverse reaction occurs during the experiment, subjects should be notified the researcher immediately.
Exclusion
- Subject who is not willing to participate in this study;
- Vegetarians;
- People with a history of organ transplantation, epilepsy or convulsions, liver and kidney disease, malignant tumors, endocrine diseases, mental illness, alcohol or drug abuse, and other major organic diseases (according to medical history);
- Participate in other clinical trials related to antioxidants and anti-aging four weeks before and during the test;
- People with a history of dyspepsia would affect the absorption of the test product;
- Allergic to the components of the test product;
- Pregnant or breast-feeding women;
- Take anti-oxidant supplements;
- Undergoing hormone replacement therapy.
Key Trial Info
Start Date :
September 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT05191056
Start Date
September 15 2021
End Date
February 28 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bo Han Wu
Pingtung City, Taiwan, 912